Concord Drugs Performance
Fundamentals of Concord Drugs
|P/E Ratio (TTM)||19.36|
|Debt to Equity||0.52|
Financials of Concord Drugs
|Dec 2022||Mar 2023||Jun 2023||Sep 2023|
|Profit before tax||0.62||0.14||0.64||0.8|
|EPS in Rs||0.52||0.17||0.53||0.6|
About Concord Drugs
CONCORD DRUGS LIMITED is a public limited company established in 1995, is among the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectabl ... es (Small volume parenterals, Dry powder ) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality. The company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide our customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing. The company operates a state of the art, cGMP contract manufacturing Formulation-Fill-Finish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products. The company has two manufacturing facilities built to comply with standards stipulated by Regulatory bodies. Read More
|Stocks||Market Cap (cr)||Market Price (₹)||52 Week Low-High (₹)|
|Supriya Lifescience Ltd||₹2,300.60||
|286 - 294.45|
|Celestial Biolabs Ltd||₹4.56||
|1.75 - 1.8|
|JFL Life Sciences Ltd||₹47.84||
|43.1 - 43.1|
|Procter & Gamble Health Ltd||₹8,530.74||
|5046.05 - 5189.95|
|Veerhealth Care Ltd||₹36.06||
|26 - 26|
What is the Share price of Concord Drugs ()?
Can I buy Concord Drugs () shares?
How do I buy Concord Drugs () from Angel One?
- Direct investment: You can buy Concord Drugs () shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Concord Drugs () shares.